Dading, Latip .

HRN: 23-56-06  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
MUPIROCIN 2%, 15G (TUBE)
01/03/2024
01/09/2024
TOPICAL
2%
BID
Nonhealing Wound, Left Foot
Waiting Final Action 
01/03/2024
CEFTRIAXONE 1G (VIAL)
01/03/2024
01/09/2024
IV
2g
OD
Nonhealing Wound
Waiting Final Action 
01/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/03/2024
01/09/2024
IVT
600mg
Q8
Non Healing Wound Left
Waiting Final Action 
01/04/2024
CEFTAZIDIME 1GM (VIAL)
01/04/2024
01/10/2024
IV
1g
Q12
Nonhealing Wound
Waiting Final Action 
01/07/2024
CLINDAMYCIN 300MG (CAP)
01/07/2024
01/13/2024
ORAL
300mg
Tid
Nonhealing Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: